Much has been written about the need to modify psychotherapeutic techniques to suit the cultural context of the Indian patient. Even the most ardent advocates of the need to make psychotherapy culturally relevant, often forget that similar modifications may also be necessary in the pharmacotherapy of psychiatric disorders. We often assume that a drug which is effective in one group of patients should be effective in the same way in patients elsewhere also. But clinical experience often shows that cultural factors influence compliance with response to drugs.
It is often suggested that the main reason lor patients not following the drug prescriptions of doctors in developing countries like India, is because these medicatioas are expensive and the practitioners of modem medicine are not as accessible as the practitioners of indigenous methods of treatment. But one often comes across patients who avoid the primary health centre or hospital nearby and travel long distances to meet the practitioners of indigenous systems of medicine or magico-religious methods and spend a great deal of money on them. Even in situations where the drugs ae freely given and the patient lives close to the hospital, compliance with instructions about medication is often poor. This implies that factors other than cost or accessibility of psychiatric services play a part in determining whether a patient follows medical advice or not.
Patients and their families' beliefs about the cause of the illiness is obviously a major I actor which influence compliance. A family which believes that the patient's psychotic symptoms are due to influence of evil spirits or witch craft will be unconvinced about the psychiatrists' ability to control the symptoms with medication md will feel comfortable if they try exorcism at li-' ast once.
Popular concepts derived from indigenous systems of medicine regarding the effect of med-PSYCHOPHARMACOLOGY ication have a profound influence on compliance. Some drags and food stuff are believed to produce excessive "heat" while others are believed to have a "cooling" effect. Generally "heat" producing items are considered to have an adverse effect on health and many allopathic drugs, including most psychopharmacological agents, are included in this category and their long term use discouraged.
While giving antipsychotics and antidepressants as a single night time dose has several advantages, such a schedule also at times leads to the misunderstanding that these are "sleeping pills" which should not be taken for a long time lest the patients gets "addicted" to it.
In addition to all the other undesirable consequences of polypharmacy, it also contributes to poor drug compliance. It often so confuses the patient and family, that they do not know which of the many medicines prescribed is the essential one for the control of the illiness and which are the non essential ones, used as padding. One often finds psychotic patients who omit antipsychotic medication, but faithfully continue the antiparkinsonian drugs and vitamins prescribed along with it; the family feels ^satisfied that the patient is "mostly" following the doctor's advice. When a relapse occurs, the family is unable to understand the reason for it and attribute it to the lack of efficacy of the treatment.
Many patients who have to be on long term treatment, whether it be with medication or chronic haemodialysis or some other modality, detest the idea that their life or well-being is dependent on an external factor and take it as an infringement of their personal autonomy. Noncompliance could be an expression of their rebellion against the dependence. Even in our culture this is a factor which influences many patients irrespective of their socio-economic status or educational level.
Side effects of psychotropic medication are one of the commonest reason for their discontinuation by psychiatric patients all over the world. Regarding this aspect as well, cultural factors are found to have significant influence. For example non-compliance with lithium in Western countries is often due to factors like the patient missing the 'highs' which he used to enjoy, fear of losing the creativity which he experience during the highs and fear of gaining weight. However, in another culture these may not be considered as serious problems while other side effects may assume greater significance, as Lee (1993a) observed in a group of lithium treated patients in Hong Kong. Lee (1993b) also reported that though side effects of lithium like polyuria and polydypsia were present in Chinese patients, they did not deter them from continuing medication because they believed that lithium caused Tiotness' and that was neutralised by drinking a lot of water which had a 'cooling' effect. Thus, although side effect profile of psychopharmacological agents may be similar in different cultures, cultural factors influence patient's attitude towards them, affecting the labelling, meaning and reporting of the symptoms.
In our culture, certain side effects have more significance for the patient than some others. Thus amenorrhoea due to antipsychotic medication and sexual dysfunction resulting from the use of antipsychotics and antidepressants are found to distress patients more than most other side effects and lead to discontinuation of medicines, which is a decision often supported by the family members.
Involvement of the family and education of the patient and family about pharmacotherapy is found to significantly reduce non-compliance (Lee 1993c) . Based on his studies on the Chinese Patients, Lee suggests that the psychiatrist should use the paternalism of traditional Chinese culture as a therapeutic ally Similarly die Indian psychiatrist could extend the "guru-chela" paradigm from psychotherapy to pharmacotherapy also. This necessarily implies that the doctor has to take the role of an educator and not either that of a demi-god or a passive observor. Prof. Channabsavanna, in his Murti Rao Oration published in this issue of the journal, draws our attention to many issues involved in the use of psychopharmacological agents including the importance of educating the patient and the family.
While everyone agrees that educating the patient and family is a major responsibility of the psychiatrist, there seems to be very little concern about the psychiatrists' need to update his knowledge or how this should be done. As Gopala sarma in his paper points out, the medical representative still remains the chief educator of many doctors.
It is widely believed that there are ethnic differences in the pharmacokinetics of psychotropic drugs (Pi etal 1993) and that Asians require less medication thatnon-Asians to achieve a therapeutic response. It is also believed that Asians are more susceptible to side effects. But systematic studies which prove these asumptions are sadly lacking. It is high time that we recognise that society, culture, environment genetics and biology have their impact not only on the genesis and manifestations of psychiatric disorders, but also on their treatment, psychosocial as well as psychopharmacological.
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